MARKET

NTRA

NTRA

Natera
NASDAQ

Real-time Quotes | Nasdaq Last Sale

37.64
+0.30
+0.80%
After Hours: 37.64 0 0.00% 16:07 01/17 EST
OPEN
37.26
PREV CLOSE
37.34
HIGH
38.25
LOW
37.10
VOLUME
688.04K
TURNOVER
--
52 WEEK HIGH
40.92
52 WEEK LOW
12.51
MARKET CAP
2.92B
P/E (TTM)
-20.2409
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NTRA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NTRA News

  • National Cancer Center Japan Launches Multi-Center Randomized Trial Using Signatera MRD Testing in Stage II-III Colorectal Cancer
  • PR Newswire.2d ago
  • Edited Transcript of NTRA earnings conference call or presentation 6-Nov-19 9:30pm GMT
  • Thomson Reuters StreetEvents.4d ago
  • Natera Announces New Early Priority Date cfDNA Patent, Files Suit Against CareDx
  • Benzinga.4d ago
  • Natera Announces New Early Priority Date cfDNA Patent, Files Suit Against CareDx
  • PR Newswire.4d ago

More

Industry

Medical Equipment, Supplies & Distribution
+0.07%
Healthcare Equipment & Supplies
+0.29%

Hot Stocks

Name
Price
%Change

About NTRA

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).
More

Webull offers Natera Inc (NTRA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.